A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

Local Institution - 0011, Berlin

Local Institution - 0002, Córdoba

Local Institution - 0012, Lübeck

Local Institution - 0013, Las Palmas de Gran Canaria

Local Institution - 0006, Clermont-Ferrand

Local Institution - 0008, Pierre-Bénite

Local Institution - 0004, Prague

Local Institution - 0009, Pardubice

Local Institution - 0010, Nice

Local Institution - 0005, Chemnitz

Local Institution - 0015, Krakow

Local Institution - 0001, Rzeszów

Local Institution - 0016, Katowice